ROBERT YOUNG: Open Payments
NPI 1184719486 · ZAVALLA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$92 in 5 payments from 4 companies in 2025. Trend: 2023 $40 · 2024 $51 · 2025 $92
Food & beverage: $92
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, KEVEYIS, Veozah, FARXIGA, Qelbree.
Industry payments across TX — which companies pay providers there.
